Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 3.1 EX-3.1
- 3.2 EX-3.2
- 4.1 EX-4.1
- 4.3 EX-4.3
- 4.4 EX-4.4
- 4.5 EX-4.5
- 4.6 EX-4.6
- 4.7 EX-4.7
- 4.8 EX-4.8
- 4.9 EX-4.9
- 4.10 EX-4.10
- 4.11 EX-4.11
- 4.12 EX-4.12
- 4.13 EX-4.13
- 4.14 EX-4.14
- 4.15 EX-4.15
- 4.16 EX-4.16
- 4.17 EX-4.17
- 4.18 EX-4.18
- 4.19 EX-4.19
- 4.20 EX-4.20
- 4.21 EX-4.21
- 4.22 EX-4.22
- 4.23 EX-4.23
- 4.24 EX-4.24
- 4.25 EX-4.25
- 5.1 EX-5.1
- 5.2 EX-5.2
- 5.3 EX-5.3
- 5.4 EX-5.4
- 5.5 EX-5.5
- 5.6 EX-5.6
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 10.7 EX-10.7
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.10 EX-10.10
- 12.1 EX-12.1
- 21.1 EX-21.1
- 23.1 EX-23.1
- 23.2 EX-23.2
- 23.3 EX-23.3
- 23.4 EX-23.4
- 25.1 EX-25.1
- 99.1 EX-99.1
- 99.2 EX-99.2
- CORRESP Corresp
Pharma similar filings
Filing view
External links
Exhibit 23.4
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated August 31, 2011, with respect to the consolidated financial statements of PDGI Holdco, Inc. included in Amendment No. 1 of the Registration Statement(Form S-4) of inVentiv Health, Inc. for the registration of $350,000,000, 10% Senior Notes due 2018.
/s/ Ernst & Young LLP
MetroPark, New Jersey
October 6, 2014